Stratos Wealth Advisors, LLC Tg Therapeutics, Inc. Transaction History
Stratos Wealth Advisors, LLC
- $1.82 Billion
- Q2 2025
A detailed history of Stratos Wealth Advisors, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Stratos Wealth Advisors, LLC holds 8,022 shares of TGTX stock, worth $254,698. This represents 0.02% of its overall portfolio holdings.
Number of Shares
8,022
Previous 8,000
0.27%
Holding current value
$254,698
Previous $315,000
8.57%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding TGTX
# of Institutions
406Shares Held
92.5MCall Options Held
2.28MPut Options Held
1.78M-
Vanguard Group Inc Valley Forge, PA15.8MShares$502 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$362 Million0.0% of portfolio
-
State Street Corp Boston, MA7.62MShares$242 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$111 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY3.05MShares$96.9 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.61B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...